David M. Wurzer - 08 Feb 2023 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
10 Feb 2023, 15:01:30 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Neil Lerner, attorney-in-fact

Key filing fact

David M. Wurzer filed Form 4 for Compass Therapeutics, Inc. (CMPX) on 10 Feb 2023.

Key facts

  • This page summarizes David M. Wurzer's Form 4 filing for Compass Therapeutics, Inc. (CMPX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 10 Feb 2023, 15:01.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMPX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+50,000
Change %
Price
$0.000000
Shares after
50,000
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$3.93
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest over 48 substantially equal monthly installments starting March 8, 2023.

SEC remarks

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .